53rd Annual Thomas L Petty Aspen Lung Conference: Systems Biology of Lung Disease

描述(由申请人提供)： 第53届托马斯·L·佩蒂·阿斯彭肺病年会的主题是“肺部疾病的系统生物学--‘Omics’时代的进展”。会议的重点是基础科学、转化科学和临床科学之间的整合，会议将集中讨论利用新技术来研究肺部疾病的发病机制、治疗和结果。主题会议以12个“最先进的”陈述为基础，将讨论单基因和复杂遗传疾病、基因组和蛋白质组方法、表观基因组、综合信息学和个性化医学。加州大学旧金山分校的医学博士迪恩·谢泼德将担任会议总结。主要目标包括：1)为临床医生和研究人员提供一个国际论坛，交流与临床问题和肺部研究有关的意见；2)满足在知识每五年翻一番的领域中公认的参与需求；3)通过与国内和国际公认的临床医生和研究人员的审查和讨论，为参与者提供一个详尽地专注于单一主题的机会；以及4)推动肺部和重症护理医学的进一步研究。 公共卫生相关性： 第53届托马斯·L·佩蒂·阿斯彭肺病年会的主题是“肺部疾病的系统生物学--‘Omics’时代的进展”。会议的重点将是基础科学、转化科学和临床科学之间的整合；会议将集中于利用新技术来研究肺部疾病的发病机制、治疗和结果。

DESCRIPTION (provided by applicant): The theme of the 53rd Annual Thomas L. Petty Aspen Lung Conference is "Systems Biology of Lung Diseases - Progress in the 'Omics' Era." With an emphasis on integration between basic, translational and clinical sciences, the meeting will focus on the utilization of newer technologies to investigate the pathogenesis, treatments, and outcomes of lung diseases. Anchored by twelve "state-of-the-art" presentations, thematic sessions will address single gene and complex genetic disorders, genomic and proteomic approaches, the epigenome, integrative informatics and personalized medicine. Dean Sheppard, MD, from the University of California San Francisco, will be the Conference Summarizer. The main objectives include 1) provide an international forum for clinicians and researchers to exchange ideas relating to clinical problems and research of the lung; 2) fill a recognized need for participation in a field where knowledge is doubling every five years; 3) provide an opportunity for participants to focus on a single topic exhaustively by review and discussion with nationally and internationally recognized clinicians and researchers; and 4) provide an impetus to further research in pulmonary and critical care medicine. PUBLIC HEALTH RELEVANCE: The theme of the 53rd Annual Thomas L. Petty Aspen Lung Conference is "Systems Biology of Lung Diseases - Progress in the 'Omics' Era." The emphasis will be on the integration between basic, translational and clinical sciences; the meeting will focus on the utilization of newer technologies to investigate the pathogenesis, treatments, and outcomes of lung diseases.